- Home
- XTNT vs SRTS Comparison
XTNT vs SRTS Comparison
Compare XTNT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XTNT | SRTS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 45.6M |
| IPO Year | 2009 | 2016 |
Fundamental Metrics
Financial Performance| Metric | XTNT | SRTS |
|---|---|---|
| Price | $0.28 | $2.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $1.03 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 90.9K | 15.7K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $53,337,000.00 | $27,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.85 | $41.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $2.66 |
| 52 Week High | $0.89 | $5.49 |
Technical Indicators
Market Signals| Indicator | XTNT | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 39.89 |
| Support Level | $0.28 | $2.75 |
| Resistance Level | $0.49 | $3.07 |
| Average True Range (ATR) | 0.02 | 0.14 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 12.98 | 25.00 |
Price Performance
Historical ComparisonAbout XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.